Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10


Schwarzenbach, Christian; Tatsch, Larissa; Vilar, Juliana Brandstetter et al.

Targeting c-IAP1, c-IAP2, and Bcl-2 eliminates senescent glioblastoma cells following temozolomide treatment

ONCOLOGY RESEARCH AND TREATMENT. Bd. 45. H. SUPPL 3. 2022 S. 49-49


Winkler, Rene; Magdefrau, Ann-Sophie; Piskor, Eva-Maria et al.

Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition

ONCOGENE. Bd. 41. H. 40. 2022 S. 4560-4572


Kaina, Bernd; Beltzig, Lea; Strik, Herwig

Temozolomide - Just a Radiosensitizer?

FRONTIERS IN ONCOLOGY. Bd. 12. 2022



Petersen, Lara; Stroh, Svenja; Schoettelndreier, Dennis et al.

The Essential Role of Rac1 Glucosylation in Clostridioides difficile Toxin B-Induced Arrest of G1-S Transition

FRONTIERS IN MICROBIOLOGY. Bd. 13. 2022


Gomez-Marin, Elena; Posavec-Marjanovic, Melanija; Zarzuela, Laura et al.

The high mobility group protein HMG20A cooperates with the histone reader PHF14 to modulate TGF beta and Hippo pathways

NUCLEIC ACIDS RESEARCH. Bd. 50. H. 17. 2022 S. 9838-9857


Arnold, Carina; Demuth, Philipp; Seiwert, Nina et al.

The Mitochondrial Disruptor Devimistat (CPI-613) Synergizes with Genotoxic Anticancer Drugs in Colorectal Cancer Therapy in a Bim-Dependent Manner

MOLECULAR CANCER THERAPEUTICS. Bd. 21. H. 1. 2022 S. 100-112


Franzese, Ornella; Torino, Francesco; Giannetti, Elisa et al.

Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 22. H. 19. 2021